DENISSE LINARES: Open Payments
NPI 1669025243 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 20 payments from 13 companies in 2025. Trend: 2023 $473 · 2024 $357 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $109 |
| Boston Scientific Corporation | 2 | $55 |
| 180 Medical, Inc. | 2 | $45 |
| COLOPLAST CORP | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $31 |
| Exact Sciences Corporation | 1 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| TOLMAR, INC. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
Products named: GEMTESA, GENTLECATH, AMS 800 Artificial Urinary Sphincter, REZDIFFRA, Cologuard Collection Kit, MYRISK, Luja Coude, MOUNJARO.
Industry payments across FL — which companies pay providers there.
